Dudediligence.

LifeVantage Corporation

LFVNNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$47.2MSep ’24$67.8MDec ’24$58.4MMar ’25$55.1MJun ’25$47.6MSep ’25$48.9MDec ’25$43.7MMar ’26$42.4MJun ’26
Net income, by quarter
$1.8MSep ’24$2.5MDec ’24$3.5MMar ’25$2.0MJun ’25$2.2MSep ’25$276,000Dec ’25$1.4MMar ’26$1.3MJun ’26
Fiscal years, by the month each ended
LineJun 2022Jun 2023Jun 2024Jun 2025Jun 2026
Revenue$206.4M$213.4M$200.2M$228.5M$182.6M
Gross profit$168.3M$170.0M$158.7M$183.7M$141.6M
Operating income$7.6M$4.3M$4.3M$12.2M$6.1M
Net income$3.1M$2.5M$2.9M$9.8M$5.1M
Operating cash flow$8.0M$6.8M$12.2M$11.9M$10.2M
Free cash flow$6.4M$3.8M$10.0M$10.5M$6.7M
Cash$20.2M$21.6M$16.9M$20.2M$14.9M
Shares outstanding12.5M12.6M12.5M12.4M12.5M